Dose-Proportionality and Intra-Individual Variability of Intracellular TFV-DP and FTC-TP in Healthy Volunteers

NCT01276600 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

NETWORK

Sponsor class

Conditions

HIV

Interventions

DRUG: Emtricitabine/tenofovir

Sponsor

HIV Prevention Trials Network